Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,008 public trials 528 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation

NCT02226861

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Improving Blood Stem Cell Collection and Transplant Procedures

NCT01517035

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, CLL (Chronic Lymphocytic Leukemia), +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)

NCT01444742

Conditions: Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

NCT01053494

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia

NCT01251627

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +12 more
Locations: Ematologia, Ospedale SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy

AOU Ospedali Riuniti di Ancona Ancona, Italy

Ematologia AOU Policlinico di Bari Bari, Italy

Istituto di Ematologia e Oncologia Medica, Policlinico S.Orsola Bologna, Italy

View all 21 locations

View Trial Details

Completed

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

NCT01246206

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

NCT00070135

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Bone Marrow Diseases, +14 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States

CCOP - Christiana Care Health Services Newark, Delaware, United States

Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States

View all 21 locations

View Trial Details

Completed

Study of Clinical Efficacy and Safety of Tosedostat in MDS

NCT02452346

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

Preparatory Work to Assess Adherence to Oral Chemotherapy

NCT02895542

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Wake Forest School of Medicine Winston-Salem, North Carolina, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

NCT02210858

Conditions: Accelerated Phase of Disease, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +21 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

University of Rochester Rochester, New York, United States

View Trial Details

Bone Marrow Diseases

Bone Marrow Diseases trial results

Related conditions